Yiling Pharmaceutical Lianhua Qingwen Capsules obtained the Liberia drug & health product registration certificate

On January 27, Yiling Pharmaceutical issued an announcement saying that Lianhua Qingwen Capsules had obtained the Liberia drug & health care product registration certificate, and the company was qualified to sell the product as an OTC drug in the Liberian market.
20 countries are approved for sale
.

Table 1: Basic information on product registration in Liberia

Source: Company Announcement

Lianhua Qingwen is an exclusive variety of Yiling, involving capsules, granules and tablets, all of which have entered the 2021 version of the National Medical Insurance Catalogue, of which Lianhua Qingwen Capsule is an OTC Category A variety
.

Figure 1: The overall domestic sales of Lianhua Qingwen (100 million yuan)

Source: Mi intranet database

According to the data of Minet.
com, Lianhua Qingwen's total sales in 2020 will be close to 4 billion in Chinese urban public hospitals, county-level public hospitals, urban community centers and township health centers (referred to as Chinese public medical institutions) terminals and Chinese urban physical pharmacy terminals.
Yuan
.

As mentioned in the announcement, as of now, Lianhua Qingwen Capsules have been sold in Hong Kong, Macau, Brazil, Indonesia, Canada, Mozambique, Thailand, Ecuador, Singapore, Laos, Kyrgyzstan, the Philippines, Kuwait, Mauritius, Uganda, Russia, Liberia, Zimbabwe, Mongolia, Uzbekistan, Kenya, Ukraine and other countries use "Chinese patent medicine", "medicine", "plant medicine", "natural health product", "food supplement", "modern plant medicine" respectively.
, "Natural Medicine" and other identities registered to obtain marketing authorization
.

At present, the global epidemic has not yet dissipated, and Lianhua Qingwen is also actively participating in the global anti-epidemic: the product has been approved for new crown indications in Kuwait and other countries, and has been selected into the white list of anti-epidemic drugs issued by the Ministry of Health in Uzbekistan.
Approved to enter the designated hospital for new coronary pneumonia, in July 2021, he was selected into the home treatment plan for mild patients with new coronary pneumonia issued by the Cambodian Ministry of Health.
This is also the first time that Chinese medicines have entered overseas countries
.

Note: The original text has been deleted

Source: company announcement, Minet database

Note: Minet.
com China's urban physical pharmacy terminal competition pattern database is an enlarged version of the urban physical pharmacy database that covers 297 cities and above cities nationwide (excluding county and rural physical pharmacies) and continuously monitors all categories
.